2767-84-2

Basic information

• Product Name: (1S)-(+)-CAMPHORQUINONE
• Synonyms: 3-dione,1,7,7-trimethyl-,(1S)-Bicyclo[2.2.1]heptane-2;7,7-trimethyl-3-dion(1s)-bicyclo[2.2.1]heptane-1;S-(+)-CAMPHORQUINONE;CAMPHORQUINONE, -S-(+)-;(+)-CAMPHORQUINONE;L-(+)-CAMPHORQUINONE;L-CAMPHORQUINONE;L-2, 3-BORNANEDIONE
• CAS NO: 2767-84-2
• Molecular Formula: C₁₀H₁₄O₂
• Molecular Weight: 166.22
• EINECS: 220-446-1
• Product Categories: Bicyclic Monoterpenes;Biochemistry;Terpenes;Ring Systems
• Mol File: 2767-84-2.mol
• Article Data: 31

Chemical Properties

• Melting Point: 197-201 °C(lit.)
• Boiling Point: 234.44°C (rough estimate)
• Flash Point: 83 °C
• Appearance: /
• Density: 0.9817 (rough estimate)
• Refractive Index: 1.4859 (estimate)
• BRN: 2613999
• CAS DataBase Reference: (1S)-(+)-CAMPHORQUINONE(CAS DataBase Reference)
• NIST Chemistry Reference: (1S)-(+)-CAMPHORQUINONE(2767-84-2)
• EPA Substance Registry System: (1S)-(+)-CAMPHORQUINONE(2767-84-2)

Safety Data

• Safety Statements: 22-24/25
• WGK Germany: 3
• F: 10
• TSCA: Yes
• Hazardous Substances Data: 2767-84-2(Hazardous Substances Data)

Usage

Chemical Properties

YELLOW POWDER

Uses

Chiral starting material.

InChI:InChI=1/C10H14O2/c1-9(2)6-4-5-10(9,3)8(12)7(6)11/h6H,4-5H2,1-3H3/t6-,10+/m0/s1

Upstream product

• 76-22-2 Camphor 
• 31571-14-9 (1R,E)-(+)-camphorquinone 3-oxime 
• 7519-74-6 thiocamphor 
• 17697-12-0 benzeneseleninic anhydride 
• 95589-30-3 (1S,2R,4R,4'R)-4'-Chloromethyl-4,7,7-trimethylbicyclo<2.2.1>heptane-2-spiro-2'-(1',3'-dioxolan)-3-one 
• 79532-63-1 1-(1-Ethoxy-3,7,7-trimethyl-2-oxo-bicyclo<2.2.1>heptyl)-4-phenyl-1,2,4-triazolidin-3,5-dion 
• 76013-16-6 3-endo-(phenylseleninyl)camphor 
• 736109-58-3 1,7,7-trimethyl-bicyclo[2.2.1]heptan-2-one 
• 663-17-2 camphorquinone monooxime 
• 104319-35-9 DL camphor-10-thiazine dioxide 
• 10334-26-6 (R)-camphorquinone 
• 63988-02-3 2-phenylselenocamphor 
• 14487-70-8 3-diazocamphor 
• 464-48-2 (1S)-camphor 

Downstream Products

• 595-29-9 camphoric anhydride 
• 15210-83-0 2,2,3-trimethyl-4-oxo-cyclohexanecarboxylic acid 
• 24268-24-4 (1S,4R)-1,7,7-trimethyl-3-(phenylimino)bicyclo[2.2.1]heptan-2-one 
• 71681-63-5 3-o-tolylimino-bornan-2-one 
• 116865-63-5 (+/-)-3-((Ξ)-3-bromo-phenylimino)-bornan-2-one 
• 71681-69-1 (+/-)-3-((Ξ)-4-bromo-phenylimino)-bornan-2-one 
• 117122-83-5 (+/-)-3-((Ξ)-2-bromo-phenylimino)-bornan-2-one 
• 110463-08-6 (+/-)-3-(3-ethoxy-phenylimino)-bornan-2-one 
• 10373-81-6 3-hydroxy-1,7,7-trimethyl-bicyclo[2.2.1]heptan-2-one 
• 91900-73-1 m-menth-3⁽⁸⁾-ene-2,6-dione 
• 13837-85-9 1,7,7-trimethylbicyclo[2.2.1]heptane-exo,exo-2,3-diol 
• 3278-94-2 homocamphorquinoline 
• 21488-68-6 (1R)-3exo-hydroxy-bornan-2-one 
• 10373-79-2 DL-3-endo-(4-Methyl-benzyl)-3-exo-hydroxy-bornan-2-on 

Relevant articles and documents

Electropolymerization of D-A type EDOT-based monomers consisting of camphor substituted quinoxaline unit for electrochromism with enhanced performance

In this study, three novel donor-acceptor type monomers based on EDOT (3,4-ethoxylene dioxy thiophene) and quinoxaline derivates were designed and synthesized through Stille coupling reaction, and further polymerized by electrochemical polymerization for electrochromic application. Specially, a quinoxaline-based acceptor with bulky and rigid camphor group was introduced into the polyEDOT backbone, which was demonstrated to be effective for the improvement of electrochromic performance. The corresponding redox active polymers PCQ-EDOT and PCQ-DEDOT performed transparent oxidation states and robust switching stability. Polymer PCQ-EDOT showed superior electrochromic performances with high optical contrast (over 50%) at 647 nm, short switching time (around 0.5 s) and high coloration efficiency (427 cm2 C?1) under a low applied potential of 0.7 V.

Selectively polymerizable compositions and methods of use in vivo

Otologic materials and methods are provided. For example, a cell-adhesive, biodegradable hydrogel scaffold loaded with time-released drugs for repairing chronic tympanic membrane perforations is disclosed, methods of making same and administering same are provided. This hydrogel may promote vascular in-growth and epithelial cell growth of the tympanic membrane with the purpose of closing the perforation and providing a barrier between the external and middle ear. The hydrogel is initially a liquid polymer that only gels upon exposure to specific conditions, such as exposure to light. This scaffold may simultaneously induce repair of the tympanic membrane while preventing or alleviating middle ear infection, thus filling a void in current tympanic membrane perforation therapies.

PYRIDAZINE DERIVATIVES AS RORC MODULATORS

Compounds of formula (I): (I) or pharmaceutical salts thereof, wherein m, n,, p, q A, B, Ri, R2, R3, R4, R5, R6and R7are as defined herein. Also disclosed are methods of making the compounds and using the compounds as RORs modulators for treatment of inflammatory diseases such as arthritis.